Genus plc (LON:GNS)
London · Delayed Price · Currency is GBP · Price in GBX 2,568.00
-20.00 (-0.77%)
Apr 21, 2026, 4:35 PM GMT
Genus Market Cap
Genus has a market cap or net worth of 1.73 billion as of April 21, 2026. Its market cap has increased by 50.46% in one year.
Market Cap
1.73B
Enterprise Value
1.95B
Revenue
672.00M
Ranking
n/a
PE Ratio
36.54
Stock Price
2,568.00
Market Cap Chart
Since January 30, 1998, Genus's market cap has increased from 31.03M to 1.73B, an increase of 5,480.72%. That is a compound annual growth rate of 15.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 1.73B | -0.27% |
| Dec 31, 2025 | 1.74B | 70.54% |
| Dec 31, 2024 | 1.02B | -28.43% |
| Dec 29, 2023 | 1.42B | -27.10% |
| Dec 30, 2022 | 1.95B | -39.35% |
| Dec 31, 2021 | 3.22B | 18.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oxford Nanopore Technologies | 1.22B |
| Oxford Biomedica | 774.97M |
| Avacta Group | 349.02M |
| PureTech Health | 322.29M |
| Scancell Holdings | 137.51M |
| Bioventix | 94.05M |
| Faron Pharmaceuticals Oy | 87.79M |
| 4basebio | 78.16M |